Integer Holdings Key Executives
This section highlights Integer Holdings's key executives, including their titles and compensation details.
Find Contacts at Integer Holdings
(Showing 0 of )
Integer Holdings Earnings
This section highlights Integer Holdings's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q1 | 2025 | 2025-04-24 | $1.27 | $1.31 |
| Read Transcript | Q4 | 2024 | 2025-02-20 | $1.46 | $1.43 |
| Read Transcript | Q3 | 2024 | 2024-10-24 | $1.36 | $1.43 |
| Read Transcript | Q2 | 2024 | 2024-07-25 | $1.24 | $1.30 |
| Read Transcript | Q1 | 2024 | 2024-04-25 | $1.12 | $1.14 |
| Read Transcript | Q4 | 2023 | 2024-02-15 | $1.34 | $1.39 |
| Read Transcript | Q3 | 2023 | 2023-10-26 | $1.05 | $1.27 |
| Read Transcript | Q2 | 2023 | 2023-07-27 | $0.99 | $1.14 |
| Read Transcript | Q1 | 2023 | 2023-05-01 | N/A | N/A |
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
$123.41
Stock Price
$4.31B
Market Cap
11.00K
Employees
Plano, TX
Location
Financial Statements
Access annual & quarterly financial statements for Integer Holdings, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $1.72B | $1.60B | $1.38B | $1.22B | $1.07B |
| Cost of Revenue | $1.26B | $1.18B | $1.02B | $884.11M | $787.74M |
| Gross Profit | $459.01M | $418.29M | $359.01M | $336.97M | $285.71M |
| Gross Profit Ratio | 26.74% | 26.20% | 26.09% | 27.60% | 26.62% |
| Research and Development Expenses | $53.42M | $63.77M | $60.92M | $51.98M | $48.47M |
| General and Administrative Expenses | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $185.20M | $175.62M | $160.58M | $141.42M | $109.01M |
| Other Expenses | $12.15M | $11.57M | $899.00K | $7.86M | $7.62M |
| Operating Expenses | $250.78M | $250.96M | $221.50M | $201.26M | $165.09M |
| Cost and Expenses | $1.51B | $1.43B | $1.24B | $1.09B | $952.83M |
| Interest Income | $- | $- | $38.63M | $31.63M | $38.22M |
| Interest Expense | $56.37M | $53.37M | $38.63M | $31.63M | $38.22M |
| Depreciation and Amortization | $4.30M | $98.84M | $101.84M | $89.60M | $87.13M |
| EBITDA | $208.24M | $256.51M | $215.40M | $215.26M | $207.56M |
| EBITDA Ratio | 12.13% | 16.07% | 15.65% | 17.63% | 19.34% |
| Operating Income | $208.24M | $167.33M | $121.33M | $135.71M | $120.61M |
| Operating Income Ratio | 12.13% | 10.48% | 8.82% | 11.11% | 11.24% |
| Total Other Income Expenses Net | $-60.67M | $-60.04M | $-45.37M | $-34.65M | $-34.41M |
| Income Before Tax | $147.56M | $107.29M | $75.96M | $101.06M | $86.21M |
| Income Before Tax Ratio | 8.60% | 6.72% | 5.52% | 8.28% | 8.03% |
| Income Tax Expense | $26.51M | $16.64M | $10.61M | $8.04M | $8.95M |
| Net Income | $119.90M | $90.65M | $66.38M | $96.81M | $77.26M |
| Net Income Ratio | 6.98% | 5.68% | 4.82% | 7.93% | 7.20% |
| EPS | $3.57 | $2.72 | $1.97 | $2.82 | $2.35 |
| EPS Diluted | $3.36 | $2.69 | $1.96 | $2.80 | $2.33 |
| Weighted Average Shares Outstanding | 33.60M | 33.32M | 33.13M | 32.99M | 32.84M |
| Weighted Average Shares Outstanding Diluted | 35.65M | 33.76M | 33.36M | 33.26M | 33.11M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | March 28, 2025 | December 31, 2024 | September 27, 2024 | June 28, 2024 | March 29, 2024 | December 31, 2023 | September 29, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | July 01, 2022 | April 01, 2022 | December 31, 2021 | October 01, 2021 | July 02, 2021 | April 02, 2021 | December 31, 2020 | October 02, 2020 | July 03, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $437.39M | $449.50M | $431.42M | $436.57M | $414.80M | $413.15M | $404.69M | $400.04M | $378.79M | $372.42M | $342.68M | $350.08M | $310.91M | $313.01M | $305.57M | $312.02M | $290.47M | $268.96M | $235.94M | $240.12M |
| Cost of Revenue | $317.07M | $332.70M | $314.85M | $324.04M | $314.41M | $302.89M | $299.14M | $294.24M | $282.11M | $274.51M | $255.96M | $257.18M | $229.44M | $231.15M | $223.70M | $223.28M | $205.98M | $195.75M | $178.01M | $182.25M |
| Gross Profit | $120.32M | $116.80M | $116.57M | $112.53M | $100.39M | $110.26M | $105.56M | $105.80M | $96.67M | $97.92M | $86.72M | $92.90M | $81.47M | $81.87M | $81.87M | $88.75M | $84.49M | $73.21M | $57.93M | $57.86M |
| Gross Profit Ratio | 27.51% | 25.98% | 27.02% | 25.78% | 24.20% | 26.69% | 26.08% | 26.45% | 25.52% | 26.29% | 25.31% | 26.54% | 26.21% | 26.15% | 26.79% | 28.44% | 29.09% | 27.22% | 24.55% | 24.10% |
| Research and Development Expenses | $14.20M | $10.61M | $11.92M | $16.10M | $15.75M | $13.26M | $14.54M | $16.88M | $19.09M | $13.84M | $16.12M | $14.87M | $16.08M | $12.74M | $12.05M | $13.74M | $13.46M | $10.59M | $11.89M | $12.75M |
| General and Administrative Expenses | $- | $33.85M | $33.85M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $13.61M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $51.16M | $47.47M | $33.85M | $37.13M | $37.84M | $45.80M | $42.10M | $45.83M | $41.89M | $41.04M | $38.20M | $41.79M | $39.56M | $36.27M | $34.27M | $35.38M | $35.50M | $35.04M | $3.61M | $33.90M |
| Other Expenses | $5.41M | $1.68M | $12.78M | $1.40M | $-182.00K | $-7.68M | $-580.00K | $-359.00K | $-760.00K | $-33.00K | $626.00K | $205.00K | $296.00K | $252.00K | $-10.00K | $-356.00K | $237.00K | $-1.75M | $-1.22M | $458.00K |
| Operating Expenses | $70.77M | $59.76M | $58.56M | $51.83M | $53.78M | $66.74M | $56.67M | $62.71M | $60.98M | $54.88M | $54.94M | $56.86M | $55.94M | $53.20M | $46.87M | $49.18M | $49.14M | $45.62M | $17.17M | $48.68M |
| Cost and Expenses | $387.84M | $392.46M | $373.41M | $375.87M | $368.19M | $369.64M | $355.81M | $356.95M | $343.09M | $329.38M | $310.91M | $314.05M | $285.38M | $284.35M | $270.57M | $272.46M | $255.12M | $241.37M | $195.18M | $230.93M |
| Interest Income | $- | $1.50M | $- | $- | $- | $- | $11.97M | $11.46M | $17.25M | $14.21M | $10.68M | $- | $1.00K | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $14.80M | $12.14M | $14.58M | $14.34M | $13.74M | $12.69M | $11.97M | $11.46M | $17.25M | $14.21M | $10.68M | $7.77M | $5.97M | $5.51M | $10.05M | $7.53M | $8.53M | $9.22M | $9.37M | $9.27M |
| Depreciation and Amortization | $47.75M | $28.93M | $28.69M | $27.23M | $26.18M | $25.09M | $19.07M | $27.18M | $26.87M | $26.08M | $25.73M | $26.02M | $25.08M | $23.21M | $22.03M | $22.07M | $22.30M | $20.32M | $19.93M | $19.58M |
| EBITDA | $49.55M | $80.32M | $86.69M | $84.47M | $74.88M | $67.11M | $63.12M | $68.53M | $60.56M | $61.26M | $53.40M | $57.69M | $44.23M | $50.07M | $54.68M | $59.38M | $54.77M | $47.90M | $34.20M | $30.79M |
| EBITDA Ratio | 11.33% | 17.87% | 20.10% | 19.35% | 18.05% | 16.24% | 15.60% | 17.13% | 15.99% | 16.45% | 15.58% | 16.48% | 14.23% | 16.00% | 17.89% | 19.03% | 18.86% | 17.81% | 14.49% | 12.82% |
| Operating Income | $49.55M | $57.03M | $58.01M | $60.70M | $46.61M | $43.51M | $48.08M | $41.58M | $34.17M | $17.63M | $29.26M | $32.71M | $22.50M | $28.66M | $33.09M | $39.35M | $34.61M | $27.59M | $39.76M | $9.19M |
| Operating Income Ratio | 11.33% | 12.69% | 13.45% | 13.90% | 11.24% | 10.53% | 11.88% | 10.39% | 9.02% | 4.73% | 8.54% | 9.34% | 7.24% | 9.16% | 10.83% | 12.61% | 11.91% | 10.26% | 16.85% | 3.83% |
| Total Other Income Expenses Net | $-62.55M | $-17.77M | $-14.59M | $-15.16M | $-14.54M | $-14.19M | $-16.00M | $-11.68M | $-18.17M | $-16.27M | $-12.26M | $-8.28M | $-8.55M | $-6.54M | $-9.91M | $-8.57M | $-9.63M | $-9.59M | $-8.36M | $-9.02M |
| Income Before Tax | $-13.00M | $39.26M | $43.42M | $40.03M | $24.73M | $29.33M | $32.08M | $29.89M | $16.00M | $20.59M | $17.00M | $24.42M | $13.95M | $22.13M | $23.18M | $30.78M | $24.98M | $18.00M | $31.40M | $165.00K |
| Income Before Tax Ratio | -2.97% | 8.73% | 10.07% | 9.17% | 5.96% | 7.10% | 7.93% | 7.47% | 4.22% | 5.53% | 4.96% | 6.98% | 4.49% | 7.07% | 7.59% | 9.86% | 8.60% | 6.69% | 13.31% | 0.07% |
| Income Tax Expense | $9.47M | $6.29M | $7.14M | $8.78M | $4.23M | $2.97M | $4.82M | $5.92M | $2.93M | $3.50M | $938.00K | $3.59M | $2.58M | $2.13M | $1.11M | $1.34M | $3.46M | $2.58M | $1.06M | $-224.00K |
| Net Income | $-22.49M | $32.70M | $35.44M | $31.25M | $20.51M | $26.36M | $27.26M | $23.97M | $13.06M | $18.12M | $16.06M | $20.84M | $11.37M | $23.79M | $22.07M | $29.43M | $21.52M | $15.43M | $30.34M | $389.00K |
| Net Income Ratio | -5.14% | 7.28% | 8.21% | 7.16% | 4.94% | 6.38% | 6.74% | 5.99% | 3.45% | 4.86% | 4.69% | 5.95% | 3.66% | 7.60% | 7.22% | 9.43% | 7.41% | 5.74% | 12.86% | 0.16% |
| EPS | $-0.66 | $0.97 | $1.05 | $0.93 | $0.61 | $0.79 | $0.82 | $0.72 | $0.39 | $0.52 | $0.48 | $0.63 | $0.34 | $0.72 | $0.67 | $0.89 | $0.65 | $0.47 | $0.92 | $0.01 |
| EPS Diluted | $-0.66 | $0.90 | $0.99 | $0.88 | $0.59 | $0.78 | $0.81 | $0.71 | $0.39 | $0.51 | $0.48 | $0.62 | $0.34 | $0.71 | $0.66 | $0.89 | $0.65 | $0.47 | $0.92 | $0.01 |
| Weighted Average Shares Outstanding | 33.92M | 33.66M | 33.66M | 33.60M | 33.48M | 33.36M | 33.35M | 33.31M | 33.26M | 33.16M | 33.15M | 33.11M | 33.09M | 33.02M | 33.01M | 32.98M | 32.96M | 32.88M | 32.86M | 32.83M |
| Weighted Average Shares Outstanding Diluted | 33.92M | 36.24M | 35.79M | 35.53M | 34.99M | 33.99M | 33.77M | 33.69M | 33.58M | 33.44M | 33.34M | 33.35M | 33.30M | 33.28M | 33.31M | 33.25M | 33.19M | 33.13M | 33.08M | 33.13M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $46.54M | $23.67M | $24.27M | $17.89M | $49.21M |
| Short Term Investments | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $46.54M | $23.67M | $24.27M | $17.89M | $49.21M |
| Net Receivables | $349.04M | $326.15M | $298.25M | $251.79M | $198.51M |
| Inventory | $247.13M | $239.72M | $208.77M | $155.70M | $149.32M |
| Other Current Assets | $28.41M | $28.13M | $27.00M | $27.61M | $15.90M |
| Total Current Assets | $671.12M | $617.67M | $558.30M | $452.98M | $412.94M |
| Property Plant Equipment Net | $579.57M | $501.41M | $400.90M | $347.15M | $299.12M |
| Goodwill | $1.02B | $1.01B | $982.19M | $924.70M | $859.44M |
| Intangible Assets | $778.29M | $783.15M | $819.89M | $807.81M | $757.22M |
| Goodwill and Intangible Assets | $1.80B | $1.79B | $1.80B | $1.73B | $1.62B |
| Long Term Investments | $- | $11.83M | $13.89M | $21.83M | $27.19M |
| Tax Assets | $8.31M | $7.00M | $6.25M | $5.71M | $4.40M |
| Other Non-Current Assets | $22.96M | $10.59M | $12.97M | $22.03M | $11.55M |
| Total Non-Current Assets | $2.41B | $2.32B | $2.24B | $2.13B | $1.96B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $3.08B | $2.94B | $2.79B | $2.58B | $2.37B |
| Account Payables | $101.50M | $120.29M | $110.78M | $76.86M | $51.57M |
| Short Term Debt | $17.35M | $10.59M | $29.64M | $35.58M | $54.36M |
| Tax Payables | $2.98M | $3.90M | $10.92M | $725.00K | $1.85M |
| Deferred Revenue | $- | $6.14M | $5.62M | $3.78M | $2.50M |
| Other Current Liabilities | $105.34M | $80.05M | $66.79M | $42.69M | $45.91M |
| Total Current Liabilities | $227.17M | $220.97M | $223.75M | $159.63M | $156.19M |
| Long Term Debt | $1.08B | $1.04B | $979.13M | $872.64M | $731.62M |
| Deferred Revenue Non-Current | $- | $- | $160.67M | $- | $- |
| Deferred Tax Liabilities Non-Current | $124.61M | $145.62M | $160.67M | $171.50M | $182.30M |
| Other Non-Current Liabilities | $25.36M | $14.37M | $13.38M | $23.74M | $30.69M |
| Total Non-Current Liabilities | $1.23B | $1.20B | $1.15B | $1.07B | $944.61M |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $1.46B | $1.42B | $1.38B | $1.23B | $1.10B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $34.00K | $33.00K | $33.00K | $33.00K | $33.00K |
| Retained Earnings | $891.25M | $771.35M | $680.70M | $614.32M | $517.52M |
| Accumulated Other Comprehensive Income Loss | $-14.04M | $20.22M | $5.33M | $27.19M | $52.69M |
| Other Total Stockholders Equity | $741.98M | $727.43M | $731.39M | $713.15M | $700.81M |
| Total Stockholders Equity | $1.62B | $1.52B | $1.42B | $1.35B | $1.27B |
| Total Equity | $1.62B | $1.52B | $1.42B | $1.35B | $1.27B |
| Total Liabilities and Stockholders Equity | $3.08B | $2.94B | $2.79B | $2.58B | $2.37B |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $3.08B | $2.94B | $2.79B | $2.58B | $2.37B |
| Total Investments | $- | $11.83M | $13.89M | $21.83M | $27.19M |
| Total Debt | $1.10B | $1.05B | $1.01B | $897.75M | $777.55M |
| Net Debt | $1.05B | $1.03B | $983.41M | $879.87M | $728.34M |
Balance Sheet Charts
| Breakdown | March 28, 2025 | December 31, 2024 | September 27, 2024 | June 28, 2024 | March 29, 2024 | December 31, 2023 | September 29, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | July 01, 2022 | April 01, 2022 | December 31, 2021 | October 01, 2021 | July 02, 2021 | April 02, 2021 | December 31, 2020 | October 02, 2020 | July 03, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $31.71M | $46.54M | $35.57M | $34.14M | $42.16M | $23.67M | $32.14M | $38.62M | $40.60M | $24.27M | $20.19M | $15.59M | $25.67M | $17.89M | $25.47M | $30.58M | $28.40M | $49.21M | $99.94M | $206.24M |
| Short Term Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1.51M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $31.71M | $46.54M | $35.57M | $34.14M | $42.16M | $23.67M | $32.14M | $38.62M | $40.60M | $24.27M | $20.19M | $15.59M | $25.67M | $17.89M | $25.47M | $30.58M | $28.40M | $49.21M | $99.94M | $206.24M |
| Net Receivables | $276.24M | $349.04M | $349.21M | $346.79M | $330.88M | $326.15M | $317.80M | $319.57M | $333.50M | $298.25M | $297.13M | $296.97M | $268.07M | $251.79M | $249.51M | $237.81M | $212.97M | $198.51M | $197.31M | $185.14M |
| Inventory | $260.10M | $247.13M | $265.42M | $272.33M | $262.87M | $239.72M | $232.16M | $228.93M | $225.28M | $208.77M | $210.46M | $194.46M | $173.31M | $155.70M | $149.24M | $147.84M | $153.81M | $149.32M | $156.86M | $172.46M |
| Other Current Assets | $134.15M | $28.41M | $79.83M | $23.72M | $32.67M | $28.13M | $27.25M | $28.82M | $29.61M | $27.00M | $28.84M | $25.99M | $27.74M | $27.61M | $18.35M | $18.02M | $14.05M | $15.90M | $44.54M | $15.66M |
| Total Current Assets | $702.20M | $671.12M | $730.03M | $676.98M | $668.57M | $617.67M | $609.34M | $615.93M | $628.99M | $558.30M | $556.62M | $533.01M | $494.79M | $452.98M | $442.57M | $434.24M | $409.24M | $412.94M | $498.65M | $579.50M |
| Property Plant Equipment Net | $625.04M | $579.57M | $568.14M | $564.19M | $544.59M | $489.59M | $440.05M | $427.71M | $412.18M | $400.90M | $355.35M | $356.24M | $349.39M | $347.15M | $297.32M | $299.60M | $299.43M | $299.12M | $296.06M | $294.97M |
| Goodwill | $1.08B | $1.02B | $1.03B | $1.04B | $1.04B | $1.01B | $979.89M | $985.98M | $986.91M | $982.19M | $965.12M | $978.56M | $923.59M | $924.70M | $849.69M | $853.31M | $852.24M | $859.44M | $851.68M | $844.97M |
| Intangible Assets | $856.21M | $778.29M | $805.17M | $813.73M | $828.85M | $783.15M | $779.12M | $797.59M | $811.46M | $819.89M | $816.00M | $841.12M | $792.39M | $807.81M | $716.06M | $730.08M | $739.33M | $757.22M | $759.42M | $762.43M |
| Goodwill and Intangible Assets | $1.94B | $1.80B | $1.84B | $1.86B | $1.87B | $1.79B | $1.76B | $1.78B | $1.80B | $1.80B | $1.78B | $1.82B | $1.72B | $1.73B | $1.57B | $1.58B | $1.59B | $1.62B | $1.61B | $1.61B |
| Long Term Investments | $- | $- | $10.23M | $9.33M | $9.33M | $11.83M | $10.42M | $13.87M | $13.73M | $13.89M | $16.22M | $19.11M | $19.43M | $21.83M | $23.35M | $25.17M | $25.86M | $27.19M | $25.81M | $23.98M |
| Tax Assets | $8.37M | $8.31M | $6.78M | $6.86M | $7.03M | $7.00M | $6.40M | $6.45M | $6.36M | $6.25M | $6.12M | $6.15M | $5.70M | $5.71M | $4.36M | $4.40M | $4.38M | $4.40M | $5.22M | $5.15M |
| Other Non-Current Assets | $23.50M | $22.96M | $14.21M | $13.15M | $13.76M | $22.42M | $14.14M | $13.81M | $13.92M | $12.97M | $23.05M | $23.90M | $22.75M | $22.03M | $14.78M | $12.34M | $12.87M | $11.55M | $12.15M | $12.44M |
| Total Non-Current Assets | $2.60B | $2.41B | $2.44B | $2.45B | $2.45B | $2.32B | $2.23B | $2.25B | $2.24B | $2.24B | $2.18B | $2.23B | $2.11B | $2.13B | $1.91B | $1.92B | $1.93B | $1.96B | $1.95B | $1.94B |
| Other Assets | $- | $- | $- | $- | $- | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $0 | $- | $- | $- |
| Total Assets | $3.30B | $3.08B | $3.17B | $3.13B | $3.12B | $2.94B | $2.84B | $2.86B | $2.87B | $2.79B | $2.74B | $2.76B | $2.61B | $2.58B | $2.35B | $2.36B | $2.34B | $2.37B | $2.45B | $2.52B |
| Account Payables | $112.02M | $101.50M | $116.84M | $119.45M | $116.22M | $120.29M | $108.35M | $107.51M | $124.28M | $110.78M | $101.15M | $103.11M | $90.02M | $76.86M | $68.42M | $69.30M | $62.40M | $51.57M | $55.40M | $54.00M |
| Short Term Debt | $8.72M | $17.35M | $13.88M | $17.46M | $17.10M | $10.59M | $19.95M | $25.15M | $30.44M | $29.64M | $36.45M | $36.77M | $36.65M | $35.58M | $36.10M | $53.39M | $53.31M | $54.36M | $54.07M | $53.70M |
| Tax Payables | $- | $2.98M | $571.00K | $461.00K | $5.96M | $3.90M | $2.28M | $3.04M | $11.05M | $10.92M | $1.36M | $259.00K | $1.35M | $725.00K | $36.00K | $34.00K | $3.61M | $1.85M | $1.07M | $4.76M |
| Deferred Revenue | $- | $- | $-3.25M | $5.07M | $5.93M | $6.14M | $4.83M | $3.03M | $6.37M | $5.62M | $6.12M | $8.72M | $7.02M | $3.78M | $36.00K | $34.00K | $3.61M | $2.50M | $1.07M | $4.76M |
| Other Current Liabilities | $85.66M | $105.34M | $91.11M | $68.63M | $62.15M | $80.05M | $72.51M | $64.14M | $59.70M | $66.79M | $59.80M | $57.58M | $45.06M | $42.69M | $51.85M | $41.40M | $42.24M | $45.91M | $42.92M | $41.18M |
| Total Current Liabilities | $206.40M | $227.17M | $222.40M | $205.99M | $201.43M | $220.97M | $203.10M | $199.83M | $225.47M | $223.75M | $198.76M | $197.73M | $173.08M | $159.63M | $156.41M | $164.13M | $161.55M | $156.19M | $153.46M | $153.65M |
| Long Term Debt | $1.35B | $1.08B | $1.16B | $1.20B | $1.23B | $1.04B | $1.01B | $1.05B | $1.06B | $979.13M | $985.41M | $996.33M | $878.64M | $872.64M | $651.79M | $674.33M | $694.78M | $731.62M | $840.64M | $970.94M |
| Deferred Revenue Non-Current | $- | $- | $- | $85.43M | $85.22M | $72.34M | $- | $- | $- | $160.67M | $176.84M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $111.20M | $124.61M | $143.24M | $144.10M | $145.20M | $145.62M | $151.39M | $152.93M | $153.03M | $160.67M | $176.84M | $178.69M | $170.91M | $171.50M | $180.60M | $181.15M | $180.78M | $182.30M | $188.79M | $187.30M |
| Other Non-Current Liabilities | $27.50M | $25.36M | $23.38M | $18.45M | $18.42M | $14.37M | $15.32M | $14.87M | $14.86M | $13.38M | $22.40M | $21.89M | $21.06M | $23.74M | $27.08M | $24.96M | $28.52M | $30.69M | $33.11M | $30.17M |
| Total Non-Current Liabilities | $1.48B | $1.23B | $1.32B | $1.37B | $1.39B | $1.19B | $1.17B | $1.22B | $1.23B | $1.15B | $1.18B | $1.20B | $1.07B | $1.07B | $859.47M | $880.44M | $904.08M | $944.61M | $1.06B | $1.19B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $1.69B | $1.46B | $1.55B | $1.57B | $1.59B | $1.41B | $1.38B | $1.42B | $1.46B | $1.38B | $1.38B | $1.39B | $1.24B | $1.23B | $1.02B | $1.04B | $1.07B | $1.10B | $1.22B | $1.34B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $35.00K | $34.00K | $34.00K | $34.00K | $34.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K | $33.00K |
| Retained Earnings | $868.76M | $891.25M | $858.54M | $823.11M | $791.86M | $771.35M | $744.99M | $717.74M | $693.77M | $680.70M | $662.58M | $646.53M | $625.69M | $614.32M | $590.53M | $568.47M | $539.04M | $517.52M | $502.09M | $471.75M |
| Accumulated Other Comprehensive Income Loss | $10.75M | $-14.04M | $26.48M | $614.00K | $7.87M | $20.22M | $-2.96M | $12.17M | $14.97M | $5.33M | $-34.60M | $-5.28M | $22.04M | $27.19M | $31.17M | $38.95M | $35.62M | $52.69M | $32.22M | $14.48M |
| Other Total Stockholders Equity | $727.16M | $741.98M | $736.12M | $730.16M | $725.25M | $727.43M | $721.28M | $715.72M | $709.17M | $731.39M | $727.05M | $722.17M | $716.59M | $713.15M | $710.51M | $707.12M | $703.03M | $700.81M | $698.65M | $695.14M |
| Total Stockholders Equity | $1.61B | $1.62B | $1.62B | $1.55B | $1.53B | $1.52B | $1.46B | $1.45B | $1.42B | $1.42B | $1.36B | $1.36B | $1.36B | $1.35B | $1.33B | $1.31B | $1.28B | $1.27B | $1.23B | $1.18B |
| Total Equity | $1.61B | $1.62B | $1.62B | $1.55B | $1.53B | $1.52B | $1.46B | $1.45B | $1.42B | $1.42B | $1.36B | $1.36B | $1.36B | $1.35B | $1.33B | $1.31B | $1.28B | $1.27B | $1.23B | $1.18B |
| Total Liabilities and Stockholders Equity | $3.30B | $3.08B | $3.17B | $3.13B | $3.12B | $2.94B | $2.84B | $2.86B | $2.87B | $2.79B | $2.74B | $2.76B | $2.61B | $2.58B | $2.35B | $2.36B | $2.34B | $2.37B | $2.45B | $2.52B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $3.30B | $3.08B | $3.17B | $3.13B | $3.12B | $2.94B | $2.84B | $2.86B | $2.87B | $2.79B | $2.74B | $2.76B | $2.61B | $2.58B | $2.35B | $2.36B | $2.34B | $2.37B | $2.45B | $2.52B |
| Total Investments | $- | $- | $10.23M | $9.33M | $9.33M | $11.83M | $10.42M | $13.87M | $13.73M | $13.89M | $16.22M | $19.11M | $19.43M | $21.83M | $23.35M | $25.17M | $25.86M | $27.19M | $25.81M | $23.98M |
| Total Debt | $1.35B | $1.10B | $1.17B | $1.21B | $1.23B | $1.04B | $1.02B | $1.06B | $1.08B | $1.01B | $1.01B | $1.02B | $904.59M | $897.75M | $679.96M | $719.77M | $740.18M | $777.55M | $886.42M | $1.02B |
| Net Debt | $1.32B | $1.05B | $1.14B | $1.18B | $1.19B | $1.02B | $984.03M | $1.02B | $1.04B | $983.41M | $991.08M | $1.01B | $878.93M | $879.87M | $654.49M | $689.19M | $711.78M | $728.34M | $786.48M | $810.29M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $119.90M | $90.65M | $66.38M | $96.81M | $77.26M |
| Depreciation and Amortization | $111.03M | $98.84M | $91.99M | $81.37M | $79.32M |
| Deferred Income Tax | $-14.11M | $-9.49M | $-17.50M | $-10.27M | $-6.97M |
| Stock Based Compensation | $24.77M | $23.28M | $21.02M | $16.18M | $9.16M |
| Change in Working Capital | $-54.62M | $-52.30M | $-75.85M | $-47.74M | $16.16M |
| Accounts Receivables | $-6.53M | $-21.08M | $-41.38M | $-17.54M | $38.15M |
| Inventory | $-18.08M | $-30.18M | $-56.72M | $4.70M | $18.44M |
| Accounts Payables | $-16.62M | $-520.00K | $26.04M | $19.52M | $-9.05M |
| Other Working Capital | $-13.39M | $-516.00K | $-3.78M | $-54.43M | $-31.38M |
| Other Non Cash Items | $18.25M | $29.23M | $30.34M | $20.32M | $6.40M |
| Net Cash Provided by Operating Activities | $205.21M | $180.21M | $116.38M | $156.67M | $181.34M |
| Investments in Property Plant and Equipment | $- | $-119.94M | $-74.73M | $-53.46M | $-51.44M |
| Acquisitions Net | $-138.54M | $-43.60M | $-126.64M | $-217.98M | $-5.22M |
| Purchases of Investments | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $304.00K | $- | $- |
| Other Investing Activities | $-56.87M | $173.00K | $639.00K | $443.00K | $82.00K |
| Net Cash Used for Investing Activities | $-195.41M | $-163.37M | $-200.42M | $-271.00M | $-56.58M |
| Debt Repayment | $16.27M | $27.62M | $94.91M | $95.59M | $-87.51M |
| Common Stock Issued | $- | $- | $150.00K | $743.00K | $3.26M |
| Common Stock Repurchased | $- | $-3.10M | $-2.93M | $-4.59M | $-3.82M |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $-2.95M | $-42.54M | $497.00K | $-9.02M | $2.75M |
| Net Cash Used Provided by Financing Activities | $13.32M | $-18.01M | $92.48M | $81.99M | $-88.58M |
| Effect of Forex Changes on Cash | $-243.00K | $570.00K | $-2.05M | $1.02M | $-516.00K |
| Net Change in Cash | $22.87M | $-598.00K | $6.39M | $-31.32M | $35.67M |
| Cash at End of Period | $46.54M | $23.67M | $24.27M | $17.89M | $49.21M |
| Cash at Beginning of Period | $23.67M | $24.27M | $17.89M | $49.21M | $13.54M |
| Operating Cash Flow | $205.21M | $180.21M | $116.38M | $156.67M | $181.34M |
| Capital Expenditure | $-105.61M | $-119.94M | $-74.73M | $-53.46M | $-51.44M |
| Free Cash Flow | $99.60M | $60.27M | $41.65M | $103.20M | $129.90M |
Cash Flow Charts
| Breakdown | March 28, 2025 | December 31, 2024 | September 27, 2024 | June 28, 2024 | March 29, 2024 | December 31, 2023 | September 29, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | July 01, 2022 | April 01, 2022 | December 31, 2021 | October 01, 2021 | July 02, 2021 | April 02, 2021 | December 31, 2020 | October 02, 2020 | July 03, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $-22.49M | $32.70M | $35.44M | $31.25M | $20.51M | $26.36M | $27.26M | $23.97M | $13.06M | $18.12M | $16.06M | $20.84M | $11.37M | $23.79M | $22.07M | $29.43M | $21.52M | $15.43M | $30.34M | $389.00K |
| Depreciation and Amortization | $29.83M | $28.93M | $28.69M | $27.23M | $26.18M | $25.09M | $24.55M | $24.44M | $24.13M | $23.35M | $22.89M | $23.21M | $22.54M | $20.89M | $20.06M | $20.12M | $20.29M | $20.32M | $19.93M | $19.58M |
| Deferred Income Tax | $4.05M | $-14.11M | $- | $- | $- | $-9.48M | $-1.00K | $1.00K | $-5.00K | $-16.53M | $- | $-260.00K | $-709.00K | $-10.03M | $-152.00K | $684.00K | $-242.00K | $-7.01M | $3.00K | $-22.00K |
| Stock Based Compensation | $6.88M | $6.04M | $6.12M | $5.77M | $6.85M | $6.18M | $5.50M | $5.50M | $6.10M | $5.05M | $5.02M | $5.96M | $5.00M | $3.95M | $3.28M | $4.25M | $4.70M | $2.93M | $2.99M | $1.50M |
| Change in Working Capital | $- | $59.40M | $-4.27M | $-20.88M | $-34.25M | $-4.96M | $-2.56M | $-1.32M | $-43.46M | $10.69M | $-18.27M | $-40.68M | $-27.58M | $-4.48M | $-3.52M | $-25.13M | $-14.60M | $38.42M | $-21.57M | $19.87M |
| Accounts Receivables | $-18.23M | $11.52M | $-9.85M | $-10.61M | $2.41M | $-6.16M | $9.68M | $14.46M | $-24.21M | $-7.88M | $4.15M | $-21.64M | $-16.00M | $4.10M | $-2.50M | $-9.77M | $-9.37M | $-3.94M | $-2.02M | $52.28M |
| Inventory | $-7.70M | $13.44M | $-4.28M | $-9.96M | $-17.27M | $-4.39M | $-4.14M | $-4.63M | $-17.02M | $2.31M | $-17.57M | $-21.32M | $-20.15M | $5.54M | $-1.74M | $6.05M | $-5.16M | $8.17M | $16.20M | $-1.57M |
| Accounts Payables | $10.21M | $-20.91M | $-2.77M | $4.40M | $2.67M | $349.00K | $-1.67M | $-12.08M | $12.88M | $514.00K | $-30.00K | $10.56M | $15.00M | $3.48M | $-893.00K | $5.50M | $11.43M | $-3.90M | $702.00K | $-24.31M |
| Other Working Capital | $- | $55.36M | $12.63M | $-4.70M | $-22.06M | $5.25M | $-6.44M | $928.00K | $-15.12M | $15.74M | $-4.82M | $-8.28M | $-6.43M | $-17.60M | $1.60M | $-26.92M | $-11.51M | $38.10M | $-36.45M | $-6.53M |
| Other Non Cash Items | $13.00M | $-49.72M | $5.52M | $80.27M | $75.36M | $11.81M | $7.55M | $3.55M | $6.36M | $10.93M | $2.07M | $9.79M | $7.55M | $5.14M | $6.89M | $3.00M | $4.76M | $1.01M | $587.00K | $4.24M |
| Net Cash Provided by Operating Activities | $31.28M | $63.23M | $71.50M | $47.23M | $23.24M | $55.00M | $62.29M | $56.15M | $6.19M | $51.60M | $27.77M | $18.85M | $18.16M | $39.26M | $48.62M | $32.36M | $36.43M | $71.10M | $32.28M | $45.56M |
| Investments in Property Plant and Equipment | $- | $-19.09M | $-26.02M | $-31.18M | $-29.07M | $-37.05M | $-25.47M | $-32.72M | $-24.69M | $-31.63M | $-20.49M | $-11.75M | $-10.86M | $-23.75M | $-11.29M | $-10.76M | $-7.66M | $-11.65M | $-9.00M | $-12.36M |
| Acquisitions Net | $-171.95M | $- | $- | $582.00K | $-139.13M | $-43.53M | $50.00K | $50.00K | $- | $-126.64M | $49.00K | $-126.51M | $465.00K | $-217.98M | $66.00K | $- | $15.00K | $5.22M | $- | $- |
| Purchases of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-304.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- | $- | $- | $- | $- | $304.00K | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $-25.21M | $48.71M | $-220.00K | $- | $-168.20M | $73.00K | $50.00K | $50.00K | $-24.69M | $126.94M | $49.00K | $122.00K | $465.00K | $362.00K | $66.00K | $- | $15.00K | $-5.21M | $24.00K | $-607.00K |
| Net Cash Used for Investing Activities | $-197.17M | $29.62M | $-26.23M | $-30.60M | $-168.20M | $-80.58M | $-25.42M | $-32.67M | $-24.69M | $-31.32M | $-20.44M | $-138.26M | $-10.40M | $-241.37M | $-11.23M | $-10.76M | $-7.64M | $-11.64M | $-8.98M | $-12.36M |
| Debt Repayment | $- | $-90.95M | $-40.82M | $-23.57M | $171.61M | $17.55M | $-43.35M | $-17.81M | $71.23M | $-14.07M | $-9.04M | $117.00M | $1.02M | $198.07M | $-37.70M | $-19.39M | $-45.38M | $-109.38M | $-129.38M | $135.62M |
| Common Stock Issued | $- | $- | $-742.00K | $429.00K | $313.00K | $-2.30M | $355.00K | $1.39M | $555.00K | $150.00K | $- | $- | $- | $743.00K | $254.00K | $224.00K | $116.00K | $3.26M | $- | $- |
| Common Stock Repurchased | $- | $- | $10.62M | $-1.28M | $-9.35M | $-31.00K | $-137.00K | $-320.00K | $-2.61M | $-856.00K | $-147.00K | $-370.00K | $-1.56M | $-1.46M | $-142.00K | $-387.00K | $-2.60M | $-951.00K | $-90.00K | $-115.00K |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $151.58M | $8.65M | $-2.33M | $-956.00K | $-8.63M | $- | $218.00K | $-7.71M | $-38.11M | $134.00K | $-147.00K | $- | $-493.00K | $-2.55M | $-5.18M | $-232.00K | $-4.29M | $-1.03M | $128.00K | $158.00K |
| Net Cash Used Provided by Financing Activities | $151.58M | $-82.30M | $-43.14M | $-24.53M | $163.29M | $17.52M | $-43.13M | $-25.52M | $33.12M | $-13.94M | $-9.19M | $116.63M | $-1.03M | $194.05M | $-42.88M | $-19.62M | $-49.56M | $-110.28M | $-129.25M | $135.78M |
| Effect of Forex Changes on Cash | $-519.00K | $425.00K | $-685.00K | $-130.00K | $147.00K | $-996.00K | $-217.00K | $61.00K | $1.72M | $-2.26M | $6.46M | $-7.29M | $1.05M | $472.00K | $380.00K | $199.00K | $-26.00K | $81.00K | $-361.00K | $7.00K |
| Net Change in Cash | $-14.83M | $10.97M | $1.44M | $-8.02M | $18.48M | $-8.47M | $-6.47M | $-1.99M | $16.33M | $4.08M | $4.59M | $-10.07M | $7.78M | $-7.59M | $-5.11M | $2.18M | $-20.80M | $-50.74M | $-106.30M | $168.99M |
| Cash at End of Period | $31.71M | $46.54M | $35.57M | $34.14M | $42.16M | $23.67M | $32.14M | $38.62M | $40.60M | $24.27M | $20.19M | $15.59M | $25.67M | $17.89M | $25.47M | $30.58M | $28.40M | $49.21M | $99.94M | $206.24M |
| Cash at Beginning of Period | $46.54M | $35.57M | $34.14M | $42.16M | $23.67M | $32.14M | $38.62M | $40.60M | $24.27M | $20.19M | $15.59M | $25.67M | $17.89M | $25.47M | $30.58M | $28.40M | $49.21M | $99.94M | $206.24M | $37.26M |
| Operating Cash Flow | $31.28M | $63.23M | $71.50M | $47.23M | $23.24M | $55.00M | $62.29M | $56.15M | $6.19M | $51.60M | $27.77M | $18.85M | $18.16M | $39.26M | $48.62M | $32.36M | $36.43M | $71.10M | $32.28M | $45.56M |
| Capital Expenditure | $- | $-19.09M | $-26.27M | $-31.18M | $-29.07M | $-37.05M | $-25.47M | $-32.72M | $-24.69M | $-31.63M | $-20.49M | $-11.75M | $-10.86M | $-23.75M | $-11.29M | $-10.76M | $-7.66M | $-11.65M | $-9.00M | $-12.36M |
| Free Cash Flow | $31.28M | $44.14M | $45.23M | $16.05M | $-5.83M | $17.94M | $36.82M | $23.42M | $-18.51M | $19.97M | $7.28M | $7.10M | $7.30M | $15.50M | $37.33M | $21.60M | $28.77M | $59.45M | $23.28M | $33.20M |
Integer Holdings Dividends
Explore Integer Holdings's dividend history, including dividend yield, payout ratio, and historical payments.
Integer Holdings News
Read the latest news about Integer Holdings, including recent articles, headlines, and updates.
Integer Holdings Corporation (ITGR) Q1 2025 Earnings Call Transcript
Integer Holdings Corporation (NYSE:ITGR ) Q1 2025 Earnings Conference Call April 24, 2025 9:00 AM ET Company Participants Sanjiv Arora - SVP-Strategy, Business Development & IR Joseph Dziedzic - President & CEO Payman Khales - President & CEO Elect Diron Smith - EVP & CFO Conference Call Participants Brett Fishbin - KeyBanc Capital Markets Craig Bijou - Bank of America Richard Newitter - Truist Securities Nathan Treybeck - Wells Fargo Andrew Cooper - Raymond James Joanne Wuensch - Citi Suraj Kalia - Oppenheimer Operator Good morning, and welcome to the Integer Holdings Corporation First Quarter 2025 Earnings Conference Call. All participants are in a listen-only mode.
Integer Announces CEO Succession Plan
~ Joseph Dziedzic to retire as President and CEO ~ ~ Payman Khales appointed President and CEO effective October 24, 2025 ~ PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that Joseph Dziedzic will retire as President and Chief Executive Officer and will step down from the Board of Directors, effective October 24, 2025. At that time, Payman Khales, Chief Operating Officer, will assume the President and CEO position and join the Company's Board.
Integer Holdings Corporation Reports First Quarter 2025 Results
~ Strong start to the year with 1Q25 financial results ~ ~ Reiterating 2025 sales and adjusted operating income outlook; raising adjusted EPS outlook ~ PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 28, 2025. First Quarter 2025 Highlights (compared to First Quarter 2024, except as noted) Sales increased 7% to $437 million, with organic growth of 6%.
What Analyst Projections for Key Metrics Reveal About Integer (ITGR) Q1 Earnings
Besides Wall Street's top -and-bottom-line estimates for Integer (ITGR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
PLANO, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on April 1, 2025, and ending at the close of business on June 30, 2025. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the Notes being converted. Any determination regarding the convertibility of the Notes during future periods will be made in accordance with the terms of the Indenture governing the Notes.
Integer Schedules First Quarter 2025 Earnings Release and Conference Call for April 24, 2025
PLANO, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it plans to release financial and operational results for first quarter 2025 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 24, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call.
Integer Holdings Corporation Announces Upsize and Pricing of Convertible Notes Offering
PLANO, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it has priced an offering of $875.0 million aggregate principal amount of 1.875% convertible senior notes due 2030 (the “Convertible Notes”). The offering was upsized from the previously announced offering size of $750.0 million aggregate principal amount of Convertible Notes.
Integer Holdings Corporation Announces Launch of Convertible Notes Offering
PLANO, Texas, March 12, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it intends to offer, subject to market and other conditions, $750.0 million aggregate principal amount of its convertible senior notes due 2030 (the “Convertible Notes”).
Integer Holdings Corporation (ITGR) Q4 2024 Earnings Call Transcript
Integer Holdings Corporation (NYSE:ITGR ) Q4 2024 Earnings Conference Call February 20, 2025 9:00 AM ET Company Participants Andrew Senn – Senior Vice President-Strategy, Business Development and Investor Relations Joe Dziedzic – President and Chief Executive Officer Diron Smith – Executive Vice President and Chief Financial Officer Conference Call Participants Brett Fishbin – KeyBanc Capital Markets Craig Bijou – Bank of America Matthew O'Brien – Piper Sandler Richard Newitter – Truist Securities Nathan Treybeck – Wells Fargo Suraj Kalia – Oppenheimer Operator Hello and welcome to the Integer Holdings Corporation Fourth Quarter 2024 Earnings Call. All lines have been placed on mute to prevent any background noise.
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2024
~ Strong 4Q and Full Year sales and profit increase versus last year ~ ~ Expect 8% to 10% sales growth in 2025 with expanding margins ~ PLANO, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2024. Unless otherwise stated, all results and comparisons are from continuing operations.
Integer to Present at Raymond James & Associates' 46th Annual Institutional Investor Conference and KeyBanc Capital Markets Healthcare Forum
PLANO, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the following upcoming investor conferences. Integer will participate at the 2025 Raymond James & Associates' 46th Annual Institutional Investor Conference, to be held March 3-5, 2025, in Orlando, Florida.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for ITGR.